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INTRODUCTION 
 
 
 
 
 
 
 INTRODUCTION 
  
Malignancies of the head of pancreas and the periampullary 
region are managed surgically by pancreaticoduodenectomy (PD). Few 
decades back PD was associated with a very high morbidity and 
mortality. Recent advancements in surgical and anaesthetic techniques 
and the improvement in peri-operative care have evolved PD into a 
procedure with acceptable morbidity and mortality. Today PD is 
associated with a mortality of less than 5% in high volume tertiary care 
centres
1 – 7
. But the morbidity rate almost remains the same (between 
30% and 60%), requiring high level peri-operative care and prolonged 
hospital stay
8
. 
 Fast-track surgery (or enhanced recovery after surgery) is an 
interdisciplinary, multimodal concept designed to accelerate 
postoperative recovery. The objectives of fast-track surgery are to 
reduce postoperative morbidity and reduce hospital stay time leading to 
an earlier return to normal life. The multimodal concept was first 
introduced in colonic surgery. Several studies have demonstrated the 
effectiveness of this programme in colonic resection
9 -17
. Most centres 
have implemented fast-track protocol in colorectal surgeries and these 
are now being extrapolated to other abdominal surgeries. Recently, fast-
 track surgery has been proposed in pancreatic surgery with encouraging 
results, but such data are sparse
8, 18, 19
. There has been no previous 
attempt at implementing fast-track surgery in PD with pancreatico-
gastrostomy as part of reconstruction. There has been hesitation in 
implementing fast-track programme after pancreatico-gastric 
anastomosis following PD, the reason being the fear of precipitating a 
leak. 
Fast-track programme combines various techniques used in the 
care of patients undergoing elective surgery like epidural or regional 
anaesthesia, minimally invasive techniques, optimal pain control and 
aggressive postoperative rehabilitation, including early enteral/oral 
feeding and ambulation. Most of the randomised trials on fast track 
surgery did not demonstrate any significant difference in terms of 
quality of life, patient satisfaction, nutritional recovery or postoperative 
lean body mass deterioration
10
. However a safe early discharge from the 
hospital by itself is a favourable outcome. Recent published studies 
have confirmed no increase in morbidity and mortality by adhering to 
these principles. But there are very few such studies and further studies 
are warranted. 
  Randomised controlled trials have also indicated that there needs 
to be changes made in rehabilitation following upper gastrointestinal 
surgeries. These include selective or non-utilisation of nasogastric tube, 
avoidance or early removal of drains and early initiation of enteral 
feeding. The above three policies may greatly contribute to the 
reduction in morbidity or mortality by avoidance of many of the 
complications associated with their use. Some of these complications 
include sinusitis, esophagitis and aspiration pneumonitis associated 
with nasogastric tube use, ascending infections associated with drain 
tubes and avoidance of gut mucosal atrophy and bacterial translocation 
secondary to it by early initiation of enteral feeding. These measures 
obviously contribute to increased patient comfort and possibly to early 
recovery.  
By reducing the common known stress responses in surgery, it 
might be possible to reduce complication rates and to achieve rapid 
recovery
8
. Comprehensive programmes have been developed with an 
aim to reduce post-operative hospital stay, through a coordinated effort 
of patient education, newer anesthetic and analgesic methods, 
pharmaceutical interventions, focused nursing, and mobilization 
actions
20
. Safety still remains the primary concern in implementing fast-
 track protocol in major surgeries like pancreatic resections and the 
positive results need to be confirmed by randomised controlled trials. 
 There have been very few studies world over and probably ours 
is the pilot study from India, evaluating fast-track protocol in major 
pancreatic surgeries like PD. The implementation of fast track 
principles following PD may reduce stress response following the major 
surgery, thereby helping reduce complication rate and promote early 
recovery. 
 In this background it is valid to evaluate these fast track 
protocols after PD, in a high volume tertiary care centre like ours where 
about 60 pancreaticoduodenectomies are done each year with a 
mortality rate of < 1 %. Such a study as this would also help to provide 
more data about these post operative rehabilitation protocols in Indian 
population following major surgeries like pancreaticoduodenectomies 
and to assess if it reduces the financial burden on the health care 
system. 
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 AIM OF THE STUDY 
 
1. To evaluate the feasibility and safety of implementing fast track 
rehabilitation protocol following pancreaticoduodenectomy with 
pancreaticogastrostomy.  
2. To evaluate whether fast track rehabilitation principles following 
pancreaticoduodenectomy is associated with faster recovery, 
reduced morbidity and reduced length of hospital stay. 
  
  
 
 
 
 
 
REVIEW OF LITERATURE 
 
 
 
 
 
 
 REVIEW OF LITERATURE 
 The surgical treatment of carcinoma head of pancreas and 
periampullary carcinomas had greatly evolved over the past 100 years. 
The first enbloc pancreaticoduodenectomy for an ampullary carcinoma 
was done by Codivilla, but this patient succumbed in the postoperative 
period
21
. In 1912, Walther Carl Eduard Kausch, a German surgeon, 
performed the first successful two-stage pancreaticoduodenectomy
22
. It 
was in 1935; Allen Oldfather Whipple presented three cases of a two-
stage operation for the resection of carcinoma in the ampullary region. 
In the 1940s, he began performing a single-stage procedure, which 
involved reconstruction with an end-to-end choledochojejunostomy, an 
end-to-side pancreaticojejunostomy, and an end-to-side 
gastrojejunostomy
23
. The initially performed 
pancreaticoduodenectomies had poor outcomes and the mortality 
ranged close to 25%, even in the 1960s and 1970s. This led to the 
procedure being condemned by many surgeons. The mortality rate has 
dramatically reduced over the past two decades
24 – 26
. Currently most of 
the high volume centres report a mortality rate of < 4%
7, 24 – 26
. This has 
been attributed to technical advancements in surgery, improvements in 
surgical techniques, anaesthetic and peri-operative care. The long term 
 outcome after surgery for pancreatic malignancy has been dismal. The 5 
year survival has been just about 25% even after achieving an R0 
resection which falls to less than 10% if the resection margins are 
positive
26
.  
 With the success of reducing mortality following PD to less than 
5%, the focus now has shifted towards reducing morbidity following 
pancreatic resections. Even after all these years and the improvements 
in peri-operative care, the morbidity has not come down significantly 
and may reach about 50%
8
. The most prevalent complications following 
PD are delayed gastric emptying, pancreatic anastomotic leak leading to 
fistula, wound infection and post pancreatectomy haemorrhage. 
 
 
 
 
 
 
 
 Delayed Gastric Emptying:  
DGE is the most common and distressing complication following 
PD with an incidence ranging between 19 – 57%26 – 30. This is one of the 
major factors contributing to increased length of hospital stay. The 
mechanism of DGE after PD is poorly understood with various 
hypothesis. The reasons are multifactorial; duodenal resection with a 
reduction in the length of the remaining duodenum, disruption of the 
vagal and sympathetic innervations to the antropyloric region and the 
decrease of plasma motilin after surgery have been implicated as the 
reasons for DGE
31 – 35
. Various definitions have been adopted in various 
studies, indicating the conundrum associated with defining DGE. The 
differences in the extent of resection, extent of lymphadenectomy and 
the method of reconstruction (gastrojejunostomy vs 
duodenojenunostomy or antecolic vs retrocolic gastrojejunostomy) have 
been suggested to have an impact on the occurrence of DGE. The 
difference in the type of surgical procedure between centres has been 
one of the major reasons contributing to the lack of a generally accepted 
definition of DGE in the past. The most common definition used in 
previous studies is the persistence of naso-gastric tube (NGT) ≥ POD 
10 with additionally one of the following:  
  
(a) emesis after NGT removal,  
(b) use of prokinetics > POD 10,  
(c) reinsertion of NGT,  
(d) failure to progress with diet;  
(2) NGT < POD 10 plus two of (a) to (d)
32
.  
Subsequently in 2007 the International Study Group of 
Pancreatic Surgery (ISGPS) introduced a revised definition for DGE 
with three grades
36 
(Table. 1). The new definition and grading of DGE 
has become the standard definition and most of the centres have begun 
using it as a routine. The use of a uniform definition makes it possible 
to compare the results of different studies. 
Table 1: ISGPS grading of DGE following pancreatic surgery. 
DGE 
grade 
NGT required 
Unable to tolerate 
solid oral intake at: 
Vomiting/gastric 
distension 
Use of 
prokinetics 
A 
4 – 7 days or  
reinsertion after POD 3 
POD 7 Yes/no Yes/no 
B 
8 – 14 days or  
reinsertion after POD 7 
POD 14 Yes Yes 
C 
> 14 days or  
reinsertion after POD 14 
POD 21 Yes Yes 
POD – Post operative day. 
  The various factors affecting the incidence of DGE after PD have 
been extensively analysed in various studies. DGE is seen after both 
classical PD and pylorus preserving PD (PPPD). There is controversy 
regarding which type of resection is associated with a reduced DGE. 
Some studies have found a higher incidence of DGE with pylorus 
preserving PD
1, 37 – 40
 whereas others claim the contrary to be true
41 – 45
. 
Similarly, an antecolic gastrojejunal reconstruction after resection is 
said to be associated with a reduced DGE when compared to a 
retrocolic reconstruction
46, 47
. Post-operative complications are 
postulated to increase the incidence of DGE. Particularly, pancreatic 
fistula, peripancreatic collection or an intra-abdominal abscess can 
contribute to the patient developing DGE. Though DGE may not be life 
threatening by itself, it can cause discomfort, increase the duration of 
postoperative hospital stay, increase hospital costs, and decrease the 
quality of life postoperatively
36
. Fast-track surgery in pancreas is 
mainly aimed at reducing DGE and thereby duration of stay in the 
hospital and treatment cost. 
The various components included in the definition of DGE are the 
following: 
 Naso-gastric tube (NGT): In some of the high volume centres, the NGT 
is removed as early as feasible (at 6 hours after surgery). There are 
reports when NGT is removed even when the patient is extubated. So 
the old definition of DGE: persistence of NGT > 10 days is considered 
outdated
36
. The ISGPS definition of DGE as need for NGT > 3 days 
seems appropriate as this would not miss out mild cases of DGE. 
Oral intake: It is customary to start liquid diet at the earliest. In many of 
the centres, liquid diet is started on the first POD or the first day after 
removal of the NGT. Once patients are able to tolerate liquid diet, they 
are progressed on to semisolid diet and finally to solid diet. Patients are 
expected to tolerate solid diet by the 7
th
 POD. If they are not able to do 
so, it amounts to DGE. 
 Grade A DGE is the mildest form and does not require any 
marked change in the post-operative management. The patients recover 
without much problem apart from the delay in instituting oral liquid and 
solid diet. Patients with Grade B or C DGE require support in the form 
of prokinetic drugs and enteral or parenteral nutrition. Many centres add 
a feeding jejunostomy with PD, so that there is an access for easy 
enteral feeding if the patient develops DGE. Grade C DGE is usually 
associated with other complications like pancreatic fistula or intra-
 abdominal collection or abscess. They may be associated with 
significant delay in discharge and there by delay in starting adjuvant 
therapy.  
Panceatic fistula (PF):  
 The incidence of PF following PD is highly variable, ranging 
from as low as 2% to as high as 20% in the past
1, 7, 48, 49
. Pancreatic 
fistula is the second commonest complication following PD, next only 
to DGE. PF can contribute by increasing the incidence of DGE. Like 
DGE, PF also did not have a standard definition. The incidence of PF 
varied among centres, according to the definition used. There were four 
different definitions for PF in literature in the past (Table. 2). 
Table 2: Different definitions of pancreatic fistula. 
Four different definitions of pancreatic fistula according to literature 
1. Output > 10 mL/d of amylase-rich ﬂuid postoperative (postop) 
day 5 or for > 5 days. 
2. Output > 10 mL/d of amylase-rich ﬂuid after postop day 8 or for 
> 8 days. 
3. Output between 25 mL/d and 100 mL/d of amylase-rich ﬂuid 
after postop day 8 or for > 8 days. 
4.  Output > than 50 mL/d of amylase-rich ﬂuid after postop day 11 
or for > 11 days. 
 
  Synonymous terminologies commonly used to mean the same 
entity are pancreatic fistula, anastomotic leak, anastomotic failure and 
anastomotic insufficiency. After a list of different ways to define 
pancreatic fistula, a common acceptable definition of PF was needed to 
help compare results. Later in 2005, the International Study Group of 
Pancreatic fistula (ISGPF) introduced the new definition with 3 grades
50 
(Table 3). This is the most common definition use today.  
 
Table 3: ISGPS grading of PF following pancreatic surgery. 
 Grade A Grade B Grade C 
Clinical conditions Well Often well 
Appearing 
ill 
Specific treatment No Yes/no Yes 
US/CT (if obtained) Negative Negative/positive Positive 
Persistent drainage 
 (after 3 weeks) 
No Usually yes Yes 
Re-operation No No Yes 
Death related to POPF No No Possibly yes 
Signs of infections No Yes Yes 
Sepsis No No Yes 
Readmission No Yes/no Yes/no 
 POPF – Post operative pancreatic fistula 
 Pancreatic fistula can be generally defined as an abnormal 
communication between  the  pancreatic  ductal  epithelium  and 
another  epithelial  surface  containing  pancreas derived,   enzyme-rich   
ﬂuid. Pancreatic fistula can result from a failure of healing of the 
pancreatic-enteric anastomosis or direct leak from a raw pancreatic 
surface. The amylase rich fluid can be seen draining from the drain 
tubes or from percutaneous drain tubes subsequently placed under 
image guidance. The fluid can be clear, milky water, dark brown or 
rarely greenish if it is close to a bilioenteric anastomosis. Radiological 
documentation is not required for making a diagnosis of PF.  
 Patients with grade A PF have no deviation from routine post-
operative management. They make a normal recovery apart from a 
delay in the removal of drain tubes. Grade B PF requires changes in the 
post-operative management in the form of keeping the patient nothing 
by mouth, enteral nutrition usually through feeding jejunostomy tubes, 
partial or total parenteral nutrition, repositioning of drain tubes under 
image guidance or somatostain analogues. Patients with Grade C PF 
require major changes in the post-operative care. In addition to those 
measures as in grade B pancreatic fistula, patients usually need 
 management and monitoring in an intensive care unit with extended 
hospital stay and a significant delay in discharge.  
 In an attempt to reduce the morbidity and the prolonged hospital 
stay associated with pancreatic fistulas, various modifications of 
pancreatic anasotomosis have been attempted. Technical modiﬁcations 
such as pancreatic duct occlusion, reinforcement of anastomosis with 
ﬁbrin glue, placement of internal stent, and pancreaticogastrostomy as 
opposed to pancreaticojejunostomy have been tried, but with no 
significant improvement in the rate of PF
51 – 55
. The somatostatin 
analogue, octreotide has been used in an effort to reduce the incidence 
of PF. But a meta-analysis did not find any benefit of using octreotide 
in reducing PF following PD
51
. Later external drainage of the pancreatic 
duct using an intra-ductal stent across the anastomosis in a duct to 
mucosa pancreaticojejunostomy (PJ) was tried. It was postulated that by 
diverting the pancreatic juice away from the anastomosis, it would 
reduce the incidence of anastomotic leakage from PJ. There are 
prospective non-randomised as well as randomised studies showing that 
such external drainage of the pancreatic duct decreased the rate of 
pancreatic fistula
56, 57
.  
 
 Post Pancreatectomy Haemorrhage (PPH): 
 Post pancreatectomy haemorrhage is a less common complication 
following PD, but could be significant and fatal at times. 
Gastrointestinal or intra-abdominal haemorrhage occurs in about 1 – 
8% of pancreatic resections and account for about 11% to 38% of 
overall mortalities following surgery
58 – 60
. The bleed can be 
intraluminal or extraluminal. PPH can be classiﬁed on the basis of 3 
criteria: (I) time of onset, (II) location and cause, and (III) severity. 
 Based on the time of onset, PPH can be differentiated into early 
and late. Previous studies have used 5 or 7 days as the cutoff to define 
early and late PPH. According to the recent ISGPS criteria, early PPH 
is defined as that occurring in the ﬁrst 24 hours postoperatively, i.e. 24 
hours after the end of the index operation, and late PPH occurring more 
than 24 hours postoperatively
61
. Early PPH is usually due to technical 
failure, lack of appropriate hemostasis during surgery or an underlying 
uncorrected perioperative coagulopathy. Late PPH commonly occur 
days or weeks after the surgery
4, 58, 62
. Late PPH may occur due to 
complications of the surgery like intraabdominal abscesses, erosion of a 
peripancreatic vessel secondary to pancreatic ﬁstula or by an intra-
abdominal drain, ulceration at the site of an anastomosis, or from an 
 arterial pseudoaneurysm that has developed following surgery (the 
commonest site being the gastroduodenal artery). 
 PPH may originate from one of the following sites
30, 58, 63 – 66
:  
(a) arterial or venous vessels in the peripancreatic region. 
(b) suture lines of the anastomoses involved in reconstruction 
(gastroenteric, duodenoenteric,  jejunojejunal or 
pancreaticoenteric). 
(c) raw areas following resection (eg, pancreas stump, 
retroperitoneum). 
(d) gastric/duodenal ulcer or diffuse gastritis which has 
developed in the post-operative period. 
(e) eroded and ruptured pseudoaneurysms.  
(f) hemobilia from previously placed endobiliary stents. 
Possible pathophysiologic explanations for late PPH include 
enzymatic digestion of the blood vessel wall by trypsin, elastase, and 
other   pancreatic exocrine enzymes secondary to a pancreatic leak. 
Other reasons could be intra-abdominal infection and collection with 
involvement of peripancreatic vessels or vascular injury during 
 resection that leads to a pseudoaneurysm
60, 67
. Vascular structures close 
to the pancreas like the stump of the gastroduodenal artery, splenic 
artery, branches of the superior mesenteric artery (eg, inferior 
pancreaticoduodenal artery), the splenic vein stump or rarely, an 
intrapancreatic artery can be the source of bleed.  
There are many classifications of PPH based on the severity. 
Earlier studies classified it as mild or severe. PPH can be termed mild, 
when there is no clinical impairment or requirement for blood 
transfusion. It falls in the severe category when more than 4 or 6 units 
of packed cells are transfused within 24 hours or there is a decrease in 
hemoglobin of more than 4 g/dl
68, 69
. The ISGPS definition categorise 
PPH as mild and severe types (Table. 4, 5). The categorization of PPH 
into mild or severe type mainly depends mainly on clinical and 
biochemical parameters, and the requirement of blood transfusion. At 
times the difference can be subtle. A patient who is considered to have 
mild PPH may develop a rebleed and shift to the severe category. 
 
 
 
 
 
  
Table 4: Definition of severity of PPH. 
Mild - Small or medium volume blood loss (from drains, nasogastric 
tube, or on ultrasonography, decrease in hemoglobin 
concentration < 3 g/dl). 
- Mild clinical impairment of the patient, no therapeutic 
consequence, or at most the need for noninvasive treatment 
with volume resuscitation or blood transfusions (2-3 units 
packed cells within 24 h of end of operation or 1-3 units if later 
than 24 h after operation). 
- No need for reoperation or interventional angiographic 
embolization; endoscopic treatment of anastomotic bleeding 
may occur provided the other conditions apply. 
Severe - Large volume blood loss (drop of hemoglobin level by ≥ 3 g/dl). 
- Clinically signiﬁcant impairment (eg, tachycardia, hypotension, 
oliguria, hypovolemic shock), need for blood transfusion ( > 3 
units packed cells). 
- Need for invasive treatment (interventional angiographic 
embolization, or relaparotomy). 
 
The differentiation is mainly for the sake of characterization and 
documentation. Even a mild PPH warrants the same vigilant monitoring 
of the patient as required in severe PPH. However, the outcomes are 
likely to be different.  
 
 
  
Table 5: ISGPS grading of PPH following pancreatic surgery. 
Grade 
Time of onset, 
location, severity 
and clinical impact 
of bleeding 
Clinical 
condition 
Diagnostic 
consequence 
Therapeutic 
consequence 
A 
Early, 
intra- or 
extra 
luminal, 
mild 
 Well 
Observation, 
blood count, US 
and, if necessary, 
CT 
No 
B 
Early, 
intra- or 
extra 
luminal, 
severe 
Later, 
intra- or 
extra 
luminal, 
mild 
Often 
well/intermediate, 
very rarely 
life-threatening 
Observation, 
blood count, US, 
CT, 
angiography, 
endoscopy 
Transfusion 
of fluid-blood, 
intermediate 
care unit  
(or ICU), 
therapeutic 
endoscopy, 
embolization, 
relaparotomy 
for early PPH 
C  
Late, 
intra- or 
extralum
inal, 
severe 
Severely 
impaired, 
life-threatening 
Angiography, 
CT, endoscopy 
Localization 
of bleeding, 
angiography 
and 
embolization, 
(endoscopy ) 
or 
relaparotomy, 
ICU 
 
 
 
  
 In grade A PPH, there is only a marginal deviation from the routine 
post-operative course of the patient. It does not have a major clinical 
impact or cause a significant delay in the patient’s discharge. Grade B 
PPH requires deviation from routine in the form of diagnostic 
investigations and therapeutic interventions. Patients may require blood 
transfusions, admission to an intermediate or intensive care unit. These 
patients frequently mandate potential invasive therapeutic interventions 
such as relaparotomy or angioembolization. As a consequence patients 
with grade B PPH usually have a prolonged hospital stay. Grade C PPH 
causes severe impairment of the patient and is potentially life 
threatening. Immediate diagnostic and therapeutic interventions are 
required. Patients may not be stable enough for angioembolisation and 
emergency re-exploration may be required. Patients frequently require 
prolonged stay in the intensive care unit. The mortality rate associated 
with grade C PPH is significantly high. There is usually a sentinel bleed 
which preceeds the bout of massive haemorrhage. It is recommended 
that when a sentinel bleed is seen, immediate angiography should be 
considered as an option for definite treatment or to bridge time to 
stabilize and prepare the patient for a relaparotomy
70
. 
 
 Drain tubes: 
 Prophylactic intra-abdominal drain tubes are usually placed after 
PD to help monitor and facilitate early identification of pancreatic 
fistula and PPH
67, 71
. So prophylactic drain tubes are placed following 
PD even in high volume centres and are usually removed around the 7
th
 
post operative day
7, 43, 72
. But placement of intra-abdominal drains is 
associated with increased rates of intra-abdominal and wound infection, 
increased abdominal pain, decreased pulmonary function, and 
prolonged hospital stay
49
. A randomised control trial has shown that 
drain tubes are not mandatory and can be omitted with no increase in 
morbidity
49
. Early removal of drains was associated with a signiﬁcantly 
decreased rate of pancreatic ﬁstula, abdominal and pulmonary 
complications. These patients also had shorter median in-hospital stay 
and reduced hospital costs
73. Patients with drain fluid amylase value ≤ 
5000 U/L on the 1
st
 post operative day are less likely to develop a 
pancreatic fistula and a delayed removal of drain tubes in these patients 
might increase the above mentioned complications
74
.  Further 
randomised trials are warranted to evaluate andclarify whether drains 
help in reducing complications following PD. According to a recent 
 meta-analysis, even when drain tubes are placed, early removal of 
drains was found to be superior when compared to late removal
75
.  
Prophylactic Somatostatin analogues: 
 As somatostatin analogues reduce the endocrine and exocrine 
pancreatic secretions, they have been used prophylactically in an 
attempt to reduce pancreatic fistulas. The practice has been 
controversial with some studies supporting the use of somatostatin 
analogues while others contradict. The incidence of pancreatic fistula 
was less in the group of patients who received somatostatin. But there 
was no difference in the rates of clinically significant pancreatic fistula 
in these patients. Based on these evidence prophylactic somatostatins 
analogues were recommended routinely after pancreatic resections
76
. 
There are many centres which routinely use somatostatin analogues in 
the dose of 100 μgms thrice daily given subcutaneously. A higher dose 
has been practiced for high risk categories like a soft pancreatic 
parenchyma and a small pancreatic duct. Though somatostatin 
analogues have been routinely used in many centres, their efficacy in 
reducing pancreatic fistula needs further evaluation and evidence to 
recommend it. 
 
 Restricted peri-operative fluid infusion:  
 Restriction of peri-operative fluid infusion has been an integral 
part of fast-track protocol in colo-rectal surgery. Excessive ﬂuid 
infusion is believed to promote submucosal intestinal oedema, reduce 
mesenteric blood ﬂow, reduce tissue oxygenation, and cause intramural 
acidosis predisposing to anastomotic breakdown
77
. It is also said to 
contribute to post-operative ileus. On the contrary, excessive fluid 
restriction can cause hypovolemia and hypoperfusion leading to organ 
dysfunction. Therefore a balance needs to be struck between these two 
situations. The effect of restricting peri-operative fluid infusion is still 
not clear and is presently at the discretion of the anaesthesiologists. The 
rates of fluid infusion are usually adjusted according to the 
haemodynamic status of the patient and the urine output. Further studies 
are required to make a definite recommendation. 
 
 
 
 
 
 Epidural analgesia: 
 Thoracic epidural analgesia is also a basic requisite of the fast-
track protocol. The advantages of epidural analgesia are the reduced 
requirement of anesthetics, improved pain control, reduced incidence of 
cardiac and pulmonary complications, reduced surgical stress response 
and early bowel recovery
78
. But epidural analgesia is not without 
problems. About one third of epidural infusions need to be stopped 
because of haemodynamic instability. A significant proportion of 
patients require analgesic supplementations because of inadequate 
analgesia
78
. In one study the use of epidural analgesia did not alter the 
bowel function, lengths of stay, morbidities, or mortality
79
. But most 
centres routinely use epidural analgesia as it offers better pain relief, 
allows the patient to ambulate earlier and enables the patient a better 
respiratory function in the post-operative period. Indirectly these 
benefits may translate into early recovery of the bowel function and a 
shorter hospital stay, though these entities have not been proven. 
Further randomised controlled studies to evaluate the effect of epidural 
analgesia in major procedures like pancreaticoduodenectomy are 
unlikely, as it has become an integral part of the peri-operative 
management. 
 Naso-gastric tube (NGT) decompression: 
 Naso-gastric tubes are routinely introduced after all major 
abdominal surgeries including pancreaticoduodenectomy as it has been 
thought to decrease postoperative ileus, respiratory complications, and 
the incidence of anastomotic leaks
80
. But these effects have not been 
proven and the benefits of a routine NGT have recently been 
questioned. The high incidence of DGE following PD has discouraged 
surgeons from eliminating the routine use of naso-gastric tube. Two 
case-control studies have shown that avoiding the routine use of 
nasogastric suction resulted in no increase in morbidity or mortality
81, 
82
. There was no difference in the rate of delayed gastric emptying, 
anastomotic leak, wound infection, wound dehiscence, and pneumonia. 
The routine use of naso-gastric tube also increased patient’s discomfort 
following surgery. The use of naso-gastric tube as a routine following 
PD needs to be reconsidered, despite the apprehension associated with 
avoiding it. Even when used, it seems ideal to remove them earlier. 
There are a few centres which remove the NGT in the operating room 
on recovery. Majority of patients do not require NGT after the first or 
the second post-operative day. Early removal of NGT seems to be 
 beneficial and must be the routine unless there are specific indications 
to retain them. 
 
Early Ambulation: 
 Early ambulation is believed to have an effect on the post-
operative functional recovery. The benefits of early ambulation include 
a reduced risk of deep vein thrombosis of the lower extremities, early 
recovery from post-operative ileus, reduced pulmonary complications 
and the possibility of an early removal of bladder catheter thereby 
reducing the risk of urinary infection
83
. However there are no studies to 
evaluate and prove these benefits following pancreatic surgery. Most of 
these effects have been extrapolated from colo-rectal surgeries. Fast-
track programmes have aimed at ambulating patients early in the post-
operative period to achieve these benefits. Early ambulation by itself 
might give the patient a sense of well being and prepares the patient 
psychologically for an early discharge. 
 
 
 
 Early oral feeds: 
 Post-operative oral intake is thought to be associated with 
increased vomiting, higher post-operative ileus and the possibility of 
anastomotic leak. So, oral feeds are usually introduced after the patient 
regains bowel function (appearance of bowel sounds). But there is no 
evidence to support this practice and early post-operative oral intake on 
the contrary, is suggested to be beneficial
84
. According to a meta-
analysis, early enteral nutrition following pancreatic surgery was 
associated with a lower incidence of post-operative complications
85
. 
Now, most of the high volume centres begin to feed patients who have 
undergone PD on the 2
nd
 post-operative day. There are centres that start 
oral liquids as early as 6 hours after surgery. Some studies have shown 
that starting early enteral feeds reduces DGE and PPH
86
. Enteral feeds 
also have the benefit of maintaining the intestinal mucosal integrity 
thereby reducing bacterial translocation across the bowel, which is 
considered an important source of sepsis. 
 
 
 
 Enhanced recovery (fast-track) concept: 
Post-operative hospital stay after PD depends mainly on 
complications including pancreatic ﬁstula, post-pancreatectomy 
hemorrhage, delayed gastric emptying, and general medical 
complications involving the cardiopulmonary systems. After the 
mortality rates after PD have fallen there has been an increased 
emphasis on achieving an uneventful post-operative period and 
reducing the length of hospital stay. Achieving this would amount to 
early discharge of the patient and return to a familiar environment 
earlier with a reduction in the treatment cost
87. “Enhanced recovery” or 
“fast-track” concepts have been introduced with an aim to facilitate 
early recovery after surgery and restore the functional capacity of the 
patients to the normal pre-operative state earlier. Most of the reports on 
fast-track programmes have shown reduction in the hospital stay and 
the treatment cost involved. This was not associated with proportionate 
decrease in the incidence of complications or mortality. It is 
questionable, whether the noted beneﬁts resulted from improvements in 
physiological factors related to patient recovery or potentially from a 
more efﬁcient discharge policy88. In addition to these factors, economic, 
social and logistic factors influence the length of hospital stay. Post-
 operative hospital stay is longer in the eastern world than in the United 
States or Europe. In the east, patients are discharged only when they 
feel confident and comfortable. Of late the importance of early recovery 
and discharge has been realized world over. The only factor which 
needs to be considered while introducing fast-track programmes is 
patient safety. Such programmes need to be promoted, but not at the 
expense of increased morbidity or complications. When considering 
major procedures like PD, these programmes have been used with 
hesitancy. Very few studies have endorsed the efficacy and safety of 
fast-track protocol following pancreaticoduodenectomy. Further studies 
are warranted to prove the safety of these programmes following PD. 
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 MATERIALS AND METHODS 
Study Design: 
 Prospective analysis and comparison with historical control 
Study Period: 
April 2012 to December 2012 
Study Setting: 
Institute of Surgical Gastroenterology and Liver Transplantation,  
Government Stanley Medical College and Hospital, Chennai. 
Inclusion Criteria: 
 All patients undergoing pancreaticoduodenectomy for either one 
of the following diagnoses in the study period were included in the 
study. 
 Carcinoma head of pancreas 
 Periampullary carcinoma 
 Distal common bile duct (CBD) growth  
 Duodenal growth  
 Chronic calcific pancreatitis with pancreatic head mass 
Any tumour / suspicious lesion in the head of pancreas requiring 
resection 
  
Exclusion Criteria: 
1. Denial of consent by the patient. 
2. Preoperative organ system failure. 
3. ASA – IV/V. 
4. Contraindication of one or more fast track strategies. 
 
 
 
 
 
 
 
 
 
 
 
 Methodology: 
Fast-track rehabilitation protocol following PD was introduced in 
the Department of Surgical Gastroenterology and Liver 
Transplantation, Stanley Medical College, Chennai, in April 2012. 
Twenty one patients underwent PD between April 2012 and December 
2012, out of which 20 patients who met the inclusion criteria were 
included in the study. One patient was excluded because patient had 
coagulopathy which prevented epidural analgesia. The patient also 
required prolonged post-operative ventilator support. These patients 
were compared with previous consecutive similar number of patients 
who underwent PD and were managed according to the traditional 
pathway. 
Pre-operative parameters – detailed demographic profile, clinical 
symptoms with duration, clinical findings, blood investigation reports 
(complete blood counts, renal function test with electrolytes, blood 
sugar, liver function test), viral marker status (HBsAg and Anti-HCV), 
upper gastrointestinal endoscopy, findings of radiological imaging (X-
ray of the chest, ultrasonogram [USG] of the abdomen with doppler, 
contrast enhanced computed tomogram [CECT] or magnetic resonance 
 imaging [MRI]) and CA 19-9 values (in requiring patients) were 
recorded. 
After assessing for operability, all patients underwent classical 
pancreatico-duodenectomy involving resection of the head and uncinate 
process of pancreas along with the pylorus of stomach, distal portion of 
CBD upto the level of cystic duct insertion with the common hepatic 
duct, whole of duodenum and the proximal portion (about 20 cms) of 
jejunum. Reconstruction included anastomosis in the form of end to 
side pancreatico gastrostomy to the posterior wall of stomach by 
dunking method in a single layer, end to side hepatico jejunostomy in 
single layer, end to side gastrojejunostomy 30 cms distal to the 
hepaticojejunostomy in two layers and a feeding jejunostomy 30 cms 
distal to gastrojejunostomy by modified Witzel’s technique using a 10 
French infant feeding tube. One or more intra-abdominal drain tubes 
were placed during surgery. A naso-gastric tube was left in situ. The 
operations were performed by team of 5 surgeons. 
Intra-operative parameters including duration of surgery, intra-
operative blood loss, amount of fluids infused intra-operatively, number 
of units of blood transfused and any intra-operative events will be 
recorded. 
 All patients received the same post operative care and 
rehabilitation according to a newly adapted “fast-track rehabilitation 
protocol” (fast track group). Patients were extubated in the operating 
room or in the post-operative ward, on the day of surgery. Epidural 
analgesia as infusion was provided in all the patients. NSAIDs or 
opioids were given if epidural analgesia was ineffective or as rescue 
analgesia. Prophylactic antibiotics were given in all the patients. 
Prophylactic pancreatic secretion inhibition with octreotide was not 
used in any of the patients. All patients received metoclopramide (30 – 
60 mg) on the 1
st
 post operative day (POD) to reduce nausea and 
vomiting.  
The naso-gastric tube was removed on the 1
st
 POD if the volume 
draining was less than 300 ml. Trickle feeds of about 20 – 30 ml / hour, 
through the feeding jejunostomy was started on the first POD. Patients 
were mobilized out of bed for a minimum of one hour on the first POD. 
The mobilization was gradually increased each day till the patient was 
out of bed for more than 4 hours on the 3
rd
 POD. The drain tube 
amylase levels were checked on the 3
rd
 POD, 7
th
 POD and subsequently 
each week if the drain tube was retained. The intra-abdominal drain 
tubes were removed on the 3
rd
 POD if there was no pancreatic or biliary 
 fistula and the volume was less than 200 ml. Oral diet was increased 
from liquid diet to semisolid diet and finally to solid diet. It was 
attempted to start the patient on solid diet on the 4
th
 POD.  
All patients were initially nursed in a post operative high 
dependency unit and later shifted to the routine ward when fit and 
appropriate; when patients were free of nausea or vomiting, reasonably 
pain free, able to sit comfortably, adequately ambulant and able to walk 
to the toilets. All post-operative events (time to remove nasogastric 
tube, time to tolerate oral liquids and solids, time to pass stools, time to 
remove drain tubes, length of hospital stay and readmission rate) 
complications (delayed gastric emptying, pancreatic fistula, post 
operative haemorrhage, biliary leak, bilioma & fistula, abdominal 
collection or abscess, peritonitis, wound complications, pulmonary, 
cardiac and renal complications) and mortality were recorded.  
The demographic profile, pre-operative parameters, intra-
operative parameters, post-operative recovery, complications, morbidity 
and mortality of the patients in the fast-track group were compared with 
those of the patients treated by the conventional pathway (conventional 
group). The conventional pathway included nasogastric decompression 
until post operative day 5, oral liquids from day 6 and soft solid diet 
 from day 7; no specific action on mobilisation was defined. Apart from 
the specific changes mentioned, the other post-operative management 
was not different between the two groups. 
All data were collected prospectively and analysed 
retrospectively in the fast-track group, where as some data like the 
incidence of nausea, vomiting and the first instance of passing flatus in 
the conventional group were retrospectively collected. Because of the 
inaccuracies of the retrospectively collected data, these factors were not 
considered for analysis. Postoperative complications were defined as 
those occurring while the patient was in-hospital and within 30 days of 
discharge. Mortality was defined as in-hospital death, irrespective of 
duration of stay, or death occurring within 30 days of discharge. 
Delayed gastric emptying (DGE), pancreatic fistula (PF) and post 
pancreatectomy haemorrhage (PPH) were defined according the 
definitions of the International Study Group for Pancreatic Surgery 
(ISGPS) 
21, 22, 50
. Details of readmission were collected from the follow 
up data. 
 
 
 
 Statistical analysis: 
 All patients operated after introduction of the protocol for fast-
track rehabilitation following PD were considered to belong to the fast-
track group even if they did not accomplish the protocol (intent-to-treat 
analysis). An equal number of patients treated by the conventional 
protocol, before the fast-track programme was introduced were 
included in the control (Conventional) group. Categorical variables 
were compared with the Fischer’s exact test, quantitative variables with 
Student’s t test and nonparametric continuous variables with Mann–
Whitney U test. A p value of < 0.05 was considered significant. Data 
analysis was performed with SPSS version 13.0 (SPSS, Chicago, 
Illinois, USA). All values are presented as mean with standard 
deviation (SD), median with range or percentages. 
  
 Protocol for fast-track programme after pancreatico duodenectomy 
 
Preoperative: 
Preoperatively patients were informed about the fast-track 
programme, including daily milestones. 
Intraoperative: 
 Thoracic epidural was inserted for post-operative analgesia. 
Postoperative: 
Day 0: Epidural analgesia ± Opioids / NSAIDs 
Day 1: Removal of Nasogastric tube if < 300 ml 
 Mobilisation out of bed for > 1 hour 
 Trickle feeding through feeding jejunostomy 
Day 2: Enhanced mobilization for > 2 hours 
 Urinary catheters removed 
Day 3: Clear oral liquids 
Removal of drainage tubes if no pancreatic or biliary fistula and 
volume less than 200 ml 
 Mobilisation for > 4 hours 
Day 4: Soft solid diet  
Day 5: Dietary increase on daily basis 
 Epidural catheter removal 
 Pharmacological support: 
Metacloperamide up to 60 mg/day iv – used to prevent nausea 
and vomiting 
 
Discharge criteria: 
Patients were considered fit to be discharged if they satisfied the 
following criteria.  
Absence of fever for > 48 hours 
 Adequate pain control with oral analgesics 
 Able to take solid food 
 Passage of normal stools 
 Adequate mobilization 
 Acceptance of discharge by the patient 
  
  
 
 
 
 
 
RESULTS 
 
 
 
 
 
 
 RESULTS 
Demographic and intra-operative variables:  
The two groups were similar in regards to demographic profile, 
clinical factors, pre-operative serum bilirubin and albumin levels 
(Table. 6). The mean (± standard deviation) age of patients was 44.2 ± 
15.9 in the fast-track group and 47.6 ± 12.0 in the conventional group 
(p = 0.45). The male : female ratio was also similar between the two 
groups; 9:11 in the fast-track group and 10:10 in the conventional 
group. There was a higher incidence of co-morbidities (7 vs 2; p = 0.12) 
in the conventional group, but it was not statistically significant. The 
indication for PD was also comparable between the two groups; 
periampullary carcinoma being the most common indication, 
accounting for about 50% of the cases in both the groups. The other 
frequent indications were carcinoma head of the pancreas, distal CBD 
growth or duodenal carcinoma (Table. 7). There was one patient with a 
neuroendocrine tumour and one patient with metastasis from a 
previously operated renal cell carcinoma of the kidney. Benign 
indications were solid pseudo papillary neoplasm in the head of 
pancreas in three patients, a serous cystadenoma and a duodenal polyp 
with intussusception.  
 The duration of surgery was slightly longer in the conventional 
group, but was not significant (mean ± standard deviation 386 ± 73.51 
vs 422.25 ± 58.99 ml; p = 0.09). The blood loss during surgery and the 
number of units of blood transfused were also similar in the two groups. 
The volume of intra-operative fluids used was significantly less in the 
fast-track group (mean ± standard deviation 2852.5 ± 788.14 vs 3600 ± 
596.48; p = 0.001). Vascular resections were not required in any of our 
patients. 
 
 
 
 
 
 
 
 
 
 
  
 
 
Table 6: Demographic and perioperative parameters in patients treated 
according to fast track and conventional pathway. 
 
Fast track  
(n = 20)* 
Conventional  
(n = 20)* 
P 
Age 44.2 ± 15.9 47.6 ± 12.0 0.45 
Sex (M:F) 9:11 10:10 1 
Co-morbidities 2 7 0.12 
Preoperative bilirubin 8.02 ± 8.09 5.98 ± 6.30 0.37 
Preoperative albumin 3.81 ± 0.41 3.57 ± 0.42 0.07 
Duration of surgery 
(min) 
386 ± 73.51 422.25 ± 58.99 0.09 
Blood loss (ml) 357.5 ± 160.4 403.25 ± 159.77 0.37 
No. of patients 
transfused 
6 8 0.74 
Intraoperative fluids 
(ml) 
2852.5 ± 
788.14 
3600 ± 596.48 0.001 
 
* Values are mean with standard deviation. 
 
 
 
  
 
 
Table 7: Indications for surgery. 
 
Diagnosis Fast track Conventional 
Periampullary carcinoma 9 11 
Carcinoma head of pancreas 3 1 
Distal CBD growth 2 3 
Duodenal carcinoma 1 3 
Solid pseudopapillary neoplasm 3 - 
Neuroendocrine tumour 1 - 
Metastasis from RCC kidney 1 - 
Serous cystadenoma - 1 
Duodenal polyp - 1 
 
 
 
 
 
 
 Post-operative course: 
The naso-gastric tube inserted during surgery, was removed on a 
median of 4 days (range, 1 – 11) in the fast-track group and on a 
median of 7 days (range, 4 – 13) in the conventional group (Table. 8). 
This was statistically significant with a p value of 0.008. Patients were 
started on oral liquids as soon as the naso-gastric tube was removed. 
Oral diet was increased in a step-like fashion from liquid diet, through 
semi-solid diet to solid diet. Patients usually tolerated solid diet within 
two days of starting liquid diet, if there were no complications. The 
naso-gastric tube was reinserted in 3 patients in the fast-track group 
(days 9, 11 and 12) and in one patient in the conventional group. In the 
fast-track group, it was because 3 patients were taken up for re-
laparotomy. The one patient in the conventional group developed 
abdominal distention and bilious vomiting, requiring reinsertion of the 
naso-gastric tube on post-operative day 7. Patients were able to tolerate 
liquid and solid diet significantly earlier in the fast-track group when 
compared to the conventional group; p values were 0.0005 and 0.0001 
respectively. Patients also passed stools earlier in the fast-track group (p 
= 0.02). 
  Most of the patients had two closed drain tubes placed in either 
flanks. Both the right and the left side drain tubes were removed earlier 
in the fast-track group (right drain tube: median 5 vs 8 days; p = 0.04 
and left drain tube: median 7.5 vs 9 days; p = 0.004). Patients were 
shifted from the post-operative high dependency ward to the routine 
ward when they were free of vomiting, reasonably pain free, able to sit 
comfortably, adequately ambulant and able to walk to the toilets. The 
number of days the patients stayed in the post-operative high 
dependency ward was less in the fast-track group, but it was not 
statistically significant (median 6 vs 7 days; p = 0.1). The post-
operative hospital stay was significantly shorter in the fast-track group 
(median 14 vs 18.5 days, p = 0.007). None of the patients were 
readmitted within a period of 30 days.  
 
 
 
 
 
 
  
 
 
Table 8: Postoperative course in patients treated according to fast 
track and conventional pathway. 
 
Fast track  
(n = 20)* 
Conventional  
(n = 20)* 
P 
Naso-gastric tube 
removed (days) 
4 (1 – 11) 7 (4 – 13) 0.008 
Oral liquid diet (days) 4 (2 – 19) 8.5 (4 – 22) 0.0005 
Oral solid diet (days) 7 (3 – 23)  10.5 (7 – 25) 0.0001 
Right drain tube removed 
(days) 
5 (3 – 20) 8 (4 – 22) 0.04 
Left drain tube removed 
(days) 
7.5 (4 – 20) 9 (6 – 21) 0.004 
Passed stools on (days) 4 (3 – 6) 5 (3 – 9) 0.02 
Stay in high dependency 
ward (days) 
6 (3 – 11)  7 (5 – 22) 0.1 
Postoperative hospital 
stay (days) 
14 (9 – 26) 18.5 (13 – 38) 0.007 
 
 * Values are median with range.  
 
 
 
 Post-operative complications:  
Complications like intra-abdominal collection, atelectasis of the 
lung, urinary tract infection and wound infection were similar in the 
two groups. Delayed gastric emptying (DGE) was significantly lesser in 
the fast track group (p = 0.02). Seven (35%) patients in the fast-track 
group and 15 (75%) in the conventional group developed DGE (Table. 
9). But most of the patients had grade A DGE; 57 % (4 out of 7) in the 
fast-track group and 66 % (10 out of 15) in the conventional group. The 
incidence of pancreatic fistula (PF) was similar in the two groups (p = 
1). There were 11 and 10 patients with PF in the fast-track and the 
conventional groups respectively. But clinically significant PF (grades 
B and C) accounted for only 3 (15 %) patients in the fast-track group 
and one (5%) patient in the conventional group.  
The incidence of post pancreatectomy haemorrhage (PPH) was 
also similar in the two groups. There were 4 patients with PPH in the 
fast-track group and 2 such patients in the conventional group. Out of 
these patients, 3 in the fast-track and one in the conventional group 
required re-laparotomy. In two patients the bleed was from the pancreas 
stump. The pancreas stump was reached through an anterior 
gastrostomy and the bleed was controlled by suture ligation. In one 
 patient the bleed was from a spurting vessel near the inferior aspect of 
the pancreas stump and in the last it was from a dilated vessel in the 
mucosal aspect of the body of the stomach. Both the patients required 
an anterior gastrotomy and suture ligation of the site of bleed.  
  There were 2 mortalities in the fast-track group and one in the 
conventional group. Both the mortalities in the fast-track group were 
related to PPH for which the patients were taken for re-laparomy. Post 
operatively both the patients developed pancreatic fistula leading on to 
sepsis and multi organ failure. The single mortality in the conventional 
group was due to a sudden massive pulmonary embolism. The patient 
had made a good recovery, but had wound infection for which 
secondary suturing was done. Patient succumbed to the massive 
pulmonary embolism. 
 
 
 
 
 
 
  
 
Table 9: Morbidity and mortality in patients treated according to 
fast track and conventional pathway. 
 
Fast 
track  
(n = 20) 
Conventional  
(n = 20) 
P 
Surgical complications 5 9 0.32 
Re-laparotomy 3 1 0.6 
Delayed gastric emptying   0.02 
     Grade A 4 10 0.03 
     Grade B 1 4 0.05 
     Grade C 2 1 1 
Pancreatic fistula   1 
     Grade A 8 9 1 
     Grade B 1 1 1 
     Grade C 2 0 0.47 
Post pancreatectomy 
haemorrhage 
  0.66 
     Grade A 1 1 1 
     Grade B 0 0 - 
     Grade C 3 1 0.6 
Mortality 2 1 1 
 
 
  
 
 
 
 
 
DISCUSSION 
 
 
 
 
 
 
 DISCUSSION 
 Advancement in the surgical techniques, better equipments and 
technology and better anaesthetic and peri-operative care have 
contributed significantly in reducing the mortality rates following 
pancreaticoduodenectomy to less than 5% in most of the high volume 
centres
1 – 7
. But they have not helped greatly reduce the morbidity rate 
and it still ranges between 30 and 60%
8
. Having brought about a 
reduction in the mortality, the focus now is towards enhancing 
recovery, reducing morbidity and shortening hospital stay. The high 
morbidity is associated with a higher physiological and psychological 
stress. In the last decade, a comprehensive multimodal peri-operative 
care programme, “fast-track programme”, has been introduced. The aim 
of such a programme is to bring about a reduction in morbidity, a faster 
post-operative recovery and a shorter hospital stay. Following the 
success of the fast-track programme in colorectal surgery, it has been 
attempted in other gastrointestinal surgeries
9 – 17
. Recently, fast-track 
surgery has also been attempted with success in pancreatic surgery
8, 18, 
19
. But there are very few studies and all previous studies are from 
centres which perform pancreaticojejunostomy following PD. This 
study has attempted to study the impact of fast-track protocol following 
 PD with pancreatico-gastrostomy. Though there is the possibility of a 
bias associated with using historical controls, the two groups were 
similar in demographic and peri-operative factors. The only difference 
was the increased volume of intravenous fluid infused intra-operatively, 
in the conventional group (mean ± SD 3600 ± 596.48 vs 2852.5 ± 
788.14 ml; p = 0.001). This was partly due to the anaesthetic protocol 
of restricting fluid infusion to the required minimum, to prevent fluid 
overload intra-operatively and partly to the slightly increased operative 
duration in the conventional group. Apart from the changes listed in the 
protocol, patients in both the group were managed similarly. The 
patients in both the group were operated by the same team of surgeons, 
as it involved a short duration. This also avoided a change in the 
learning curve. 
 Most patients undergoing PD has significant nausea and 
vomiting, which prevented early enteral feeds. Contrary to earlier 
belief, nausea and vomiting was not precipitated by the early removal 
of naso-gastric tube. Retaining the naso-gastric tube for a longer 
duration only postponed the occurrence of nausea or vomiting and did 
not prevent it
18
. It also prolonged the discomfort of the patient
18
. There 
are recent data to suggest that routine naso-gastric tube is unnecessary 
 in elective abdominal surgery and can lead to increased incidence of 
pulmonary complications
89
. When pancreaticogastrostomy (PG) is 
done, there is a tendency to retain the naso-gastric for a longer duration 
in an attempt to decompress the stomach and reduce the risk of an 
anastomotic leak. But, it was possible to remove the naso-gastric tube in 
a median (range) of 4 (1 – 11) days with no increase in incidence of 
pancreatic fistula. 
 Patients were able to tolerate oral liquid and solid diet earlier in 
the fast-track group. This amounted to a significantly less DGE in the 
fast-track group when compared to the conventional group. It is also 
postulated that early post-operative feeding might improve gastric 
emptying and peristalsis in the intestine
90
, thereby reducing DGE. DGE 
is one of the most common and distressing complications of PD, with 
reported rates of 20 – 30%91. Early ambulation is said to reduce post-
operative ileus, but the issue is controversial
92
. The higher incidence of 
DGE in the present study (35% in the fast-track group and 75% in the 
conventional group) is due to the use of the International Study Group 
of Pancreatic Surgery (ISGPS) definition of DGE
93
. The earlier studies 
have used the previous commonly used definition: the need for a naso-
gastric tube or emesis after day 10
4, 43, 93, 94
. Despite the increased 
 incidence of DGE, it was worthwhile to note that majority of the DGE 
belonged to grade A; 57% (4 out of 7) in the fast-track group and 66% 
(10 out of 15) in the conventional group.  
 Another significant finding was that starting the patient earlier on 
oral diet did not increase the incidence of pancreatic fistula. The higher 
incidence of PF in this study per se, is the consequence of applying the 
ISGPF definition for PF
50
. But similar to DGE, most of the PF belonged 
to grade A (8 out of 11 in the fast-track group and 9 out of 10 in the 
conventional group). These patients did not have a change in the course 
of post-operative recovery nor did they require any specific 
intervention. The incidence of clinically significant PF (grade B or C) 
was only 3 in the fast-track group and one in the conventional group. 
There was no difference in the rates of post pancreatectomy 
haemorrhage and other non-specific complications between the two 
groups. The mortality rate was similar and there was also no difference 
in the 30 day readmission rate. 
 Contrary to expectations, the length of stay in the post-operative 
high dependency ward was not different between the two groups. This 
was probably due to hesitancy in shifting patients to the general ward 
earlier, as these were the first set of patients treated by fast-track 
 surgery. Further experience might add confidence and help reduce the 
stay in the high dependency ward. 
 The most important difference was the decrease in post-operative 
hospital stay in the fast-track group. The reduced hospital stay was 
attributed mainly to the decrease in DGE, with patients tolerating oral 
diet earlier. Early ambulation with no increase in morbidity or 
complications added to the sense of well being and the patient’s 
acceptance to return home. Length of hospital stay is an indirect 
indicator of the hospital cost involved. So, a shorter hospital stay 
amounts to a decrease in overall cost involved, as the implementation of 
fast-track programme did not involve any specific costly intervention.  
 
 
 
 
 
 
  
 
 
 
 
CONCLUSION 
 
 
 
 
 
 
 CONCLUSION 
 Implementation of fast-track programme is associated with early 
recovery, early feeding, early passage of stools, early removal of drains 
and early discharge. Despite earlier concerns with fast-track surgery, it 
did not increase the complication rate, morbidity and mortality.  Fast-
track programme appears to be feasible and safe after 
pancreaticoduodenectomy, even with pancreatico-gastric anastomosis. 
This protocol is practical and can be easily introduced with no increase 
in cost. The reduced incidence of DGE might contribute to shorter 
hospital stay and eventually to a reduced treatment cost. Further studies 
are needed to evaluate the impact of fast-track approach and optimize 
the protocol.  Experience in implementing the protocol might contribute 
to further enhancing recovery and reducing hospital stay, in high 
volume centres.  
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 Impact of fast track rehabilitation protocol following 
pancreaticoduodenectomy 
Patient’s Details Proforma 
Demographic profile: 
Name:     Age:  Sex:   M / F  I.P. No:  
Occupation:    Income:   
Address: 
Date of Admission:   Date of Surgery:   Date of Discharge: 
Length of hospital stay:  Total:  Days  Post Op:  Days 
Clinical details: 
Symptoms: Rt hypochondrial pain / Jaundice / Fever / Pruritus / Vomiting / Haematemesis / 
Melena / Anorexia / loss of weight/ Others –  
Duration of Symptoms: 
Treatment history:  ERCP & Stenting / PTBD / Others –  
Previous surgeries: 
Family History:        Alcoholic / Smoker 
Co-morbidities:  DM / HT / TB / BA / IHD / Hypothyroidism / Others 
Details: 
Clinical Examination:        Hepatomegaly / Distended GB / Lymphadenopathy / Ascites / Distant 
Metastases 
Others: 
Investigations: 
Hb:  PCV:  TC:  DC:  P         %  L         %  E         %  M        
% 
ESR:       Platelets:  PT/INR:  Bl.Sugar:  
Urea/Creat:  Na+  K+  Cl
- 
 
LFT: TB:  DB:  AST:  ALT:  GGT:  
 SAP:  TP:  Alb:  Glo:    
CA 19-9                
IU/ml 
HBsAg:  Anti-HCV:  
CXR:  ECG:  
 
OGD: 
 
USG: 
  
CECT/MRI: 
Intraoperative Parameters: 
GJ:    Antecolic / Retrocolic   Associated vascular resection:   Yes / No 
Operative time:   min   Blood loss:  ml 
Blood transfusion (units):   PC:  FFP:  Platelets:   
Intraoperative fluids:  ml  Intra Op Complications: 
Post Operative Recovery / Complications: 
I.V. Fluids on the DOS:  ml   First passed stools on: 
 POD 
RT removed on:   POD   FJ feeding started on: 
 POD 
Oral Sips started on:  POD    Solid diet started on: 
 POD  
Shifted to ward on:  POD 
Drain tubes:  
 
  
 
Biliary fistula:  Yes / No       Intra abdominal collection:  Yes / No Wound Infection:     Yes / 
No 
Others: 
Post operative Intervention: 
Histopathological Report: 
Tumour size:  Grade:      Stage:   T N M 
Lymphovascular invasion:    Yes / No 
Nodal status: 
Margin status: 
  
DT Amylase POD 3 POD 7 POD Removed on 
Right DT     
Left DT     
Complications Yes / No Grade (ISGPS) 
Delayed Gastric Emptying  A B C 
Pancreatic Fistula  A B C 
Post Operative Haemorrhage  A B C 
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